stars 1 stars 2 stars 3

Opocrin Group is engaged in pharmaceutical research and development, production and commercialization of active ingredients and new therapeutic solutions. From active ingredient to specialty pharmaceutical, work ethic and passion have led us to be global market leader in the heparin derivatives market. But this is only the beginning. We reason as innovators, we work with expertise and dedication, we produce together people who care about people. Putting the power of science at the service of life. Fully paid-up share capital € 3,000,000.00 Fiscal Code / VAT No. / Companies House of Modena No. 00156140360

OPOCRIN GROUP Questions

Giovanni Caglio is the Chief Commercial Officer of OPOCRIN GROUP.

131 people are employed at OPOCRIN GROUP.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users